Search Results - "Lambrelli, Dimitra"

Refine Results
  1. 1

    Strategies to Address Current Challenges in Real-World Evidence Generation in Japan by Laurent, Thomas, Lambrelli, Dimitra, Wakabayashi, Ryozo, Hirano, Takahiro, Kuwatsuru, Ryohei

    Published in Drugs -- real world outcomes (01-06-2023)
    “…The generation of real-world evidence (RWE), which describes patient characteristics or treatment patterns using real-world data (RWD), is rapidly growing more…”
    Get full text
    Journal Article
  2. 2

    Short and long-term costs among women experiencing preterm labour or preterm birth: the German experience by Pokras, Shibani, Pimenta, Jeanne, Merinopoulou, Evie, Lambrelli, Dimitra

    Published in BMC pregnancy and childbirth (04-07-2018)
    “…Preterm labour and birth (PTL/PTB) is characterised by major health and developmental risks for children, life-changing consequences for their families, and…”
    Get full text
    Journal Article
  3. 3

    Adverse infant outcomes following low-risk pregnancies in England: a retrospective cohort study by Riley, Megan, Lambrelli, Dimitra, Graham, Sophie, Henry, Ouzama, Sutherland, Andrea, Schmidt, Alexander, Sawalhi-Leckenby, Nicola, Donaldson, Robert, Stoszek, Sonia K

    Published in BMC pregnancy and childbirth (09-05-2023)
    “…There are limited data describing adverse infant outcomes in infants born to women with a low risk of complications during pregnancy, such as those who may be…”
    Get full text
    Journal Article
  4. 4

    Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD by Monteagudo, Mònica, Barrecheguren, Miriam, Solntseva, Iryna, Dhalwani, Nafeesa, Booth, Alison, Nuñez, Alexa, Lambrelli, Dimitra, Miravitlles, Marc

    Published in NPJ primary care respiratory medicine (22-03-2021)
    “…There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Burden of Pertussis in Adults Aged 50 Years and Older: A Retrospective Database Study in England by Harrington, Lauriane, Aris, Emmanuel, Bhavsar, Amit, Jamet, Nicolas, Akpo, Essè Ifèbi Hervé, Simeone, Jason C., Ramond, Anna, Lambrelli, Dimitra, Oppenheimer, John, Sergerie, Yan, Mukherjee, Piyali, Meszaros, Kinga

    Published in Infectious diseases and therapy (01-04-2023)
    “…Introduction Pertussis, a highly infectious respiratory disease caused by Bordetella pertussis , affects people of all ages. Older adults are particularly…”
    Get full text
    Journal Article
  8. 8

    An analysis of characteristics of post-authorisation studies registered on the ENCePP EU PAS Register [version 2; peer review: 2 approved] by Carroll, Robert, Ramagopalan, Sreeram V, Cid-Ruzafa, Javier, Lambrelli, Dimitra, McDonald, Laura

    Published in F1000 research (2017)
    “…Background: The objective of this study was to investigate the study design characteristics of Post-Authorisation Studies (PAS) requested by the European…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Decrease in rate of multiple sclerosis-related hospitalizations in Portugal [version 1; peer review: 2 approved] by Pereira, Marta, Lambrelli, Dimitra, Ramagopalan, Sreeram V

    Published in F1000 research (2016)
    “…We sought to investigate the rate of multiple sclerosis (MS)-related hospitalizations in Portugal and assess whether there have been temporal changes as…”
    Get full text
    Journal Article
  11. 11

    Incidence and prevalence of venous thromboembolism in Norway 2010–2017 by Ghanima, Waleed, Brodin, Ellen, Schultze, Anna, Shepherd, Leah, Lambrelli, Dimitra, Ulvestad, Maria, Ramagopalan, Sreeram, Halvorsen, Sigrun

    Published in Thrombosis research (01-11-2020)
    “…•Venous thromboembolism (VTE) is a major cause of mortality and morbidity worldwide.•Data on VTE patients was extracted from the Norwegian Patient…”
    Get full text
    Journal Article
  12. 12
  13. 13

    H01 Disease burden in patients with huntington’s disease from a nationwide swedish registry compared with the general population (2002–2019) by Furby, Hannah, Moore, Suzanne, Nordstroem, Anna-Lena, Houghton, Richard, Graham, Sophie, Lambrelli, Dimitra, Svenningsson, Per, Petersén, Åsa

    “…BackgroundGiven the rarity of Huntington’s disease (HD), large cohort studies are warranted to better understand the clinical burden of disease in routine…”
    Get full text
    Journal Article
  14. 14

    Real-world data in the United Kingdom: opportunities and challenges by McDonald, Laura, Lambrelli, Dimitra, Wasiak, Radek, Ramagopalan, Sreeram V

    Published in BMC medicine (24-06-2016)
    “…Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The…”
    Get full text
    Journal Article
  15. 15

    Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain by Monteagudo, Mònica, Nuñez, Alexa, Solntseva, Iryna, Dhalwani, Nafeesa, Booth, Alison, Barrecheguren, Miriam, Lambrelli, Dimitra, Miravitlles, Marc

    Published in Archivos de bronconeumologia (01-03-2021)
    “…[Display omitted] Recent data from real world clinical practices on the use of Triple Therapy (TT) in patients with COPD are scarce. Observational…”
    Get full text
    Journal Article
  16. 16

    Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns by Ghanima, Waleed, Schultze, Anna, Donaldson, Robert, Brodin, Ellen, Halvorsen, Sigrun, Graham, Sophie, Carroll, Robert, Ulvestad, Maria, Lambrelli, Dimitra

    Published in Clinical therapeutics (01-07-2021)
    “…Data describing treatment patterns of patients with venous thromboembolism (VTE) patients in Scandinavia are scarce. This study sought to address this scarcity…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients by Booth, Alison, Bell, Timothy J, Halhol, Sonia, Pan, Shiyu, Welch, Verna L, Merinopoulou, Evie, Lambrelli, Dimitra, Cox, Andrew

    Published in Blood (29-11-2018)
    “…Objectives: Treatment options for patients with AML/MDS who are ineligible for intensive chemotherapy are limited. Due to rapid progression of the condition it…”
    Get full text
    Journal Article
  19. 19

    Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective by Booth, Alison, Bell, Timothy J, Halhol, Sonia, Pan, Shiyu, Welch, Verna L, Merinopoulou, Evie, Lambrelli, Dimitra, Cox, Andrew

    Published in Blood (29-11-2018)
    “…Objectives: For patients with AML/MDS who are ineligible for intensive chemotherapy, prognosis is poor and effective treatment options are limited, often…”
    Get full text
    Journal Article
  20. 20

    Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease: a study of linked Swedish National Registries (2002–2019) by Furby, Hannah, Moore, Suzanne, Nordstroem, Anna-Lena, Houghton, Richard, Lambrelli, Dimitra, Graham, Sophie, Svenningsson, Per, Petersén, Åsa

    Published in Journal of neurology (01-02-2023)
    “…Background Huntington’s disease (HD) is a rare, neurodegenerative disease and its complex motor, cognitive and psychiatric symptoms exert a lifelong clinical…”
    Get full text
    Journal Article